Đukanović, Ljubica

Link to this page

Authority KeyName Variants
orcid::0000-0002-4429-9775
  • Đukanović, Ljubica (5)
Projects

Author's Bibliography

Increased Glomerular Filtration Rate in Early Stage of Balkan Endemic Nephropathy

Đukanović, Ljubica; Lezaić, Višnja; Bukvić, Danica; Mirković, Duško; Marić, Ivko

(MDPI, Basel, 2019)

TY  - JOUR
AU  - Đukanović, Ljubica
AU  - Lezaić, Višnja
AU  - Bukvić, Danica
AU  - Mirković, Duško
AU  - Marić, Ivko
PY  - 2019
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3247
AB  - Background: A previous study indicated that Balkan endemic nephropathy (BEN) patients in the early stage of the disease had significantly higher creatinine clearance (Ccr) than healthy persons. The aim of the study was to assess whether tubular creatinine secretion affects Ccr in early stages of BEN and to check the applicability of serum creatinine-based glomerular filtration rate (GFR) equations in these patients. Methods: The study involved 21 BEN patients with estimated GFR (eGFR) above 60 mL/min/1.73 m(2), excluding any conditions that could affect GFR or tubular creatinine secretion, and 15 healthy controls. In all participants Ccr with and without cimetidine and iohexol clearance (mGFR) were measured and eGFR calculated using Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease Study (MDRD) equations. Glomerular hyperfiltration cutoff (GFR-HF) was calculated. Results: There was no significant difference between the groups in Ccr before and after cimetidine or for eGFR, but mGFR was significantly higher in BEN patients than in controls (122.02 +/- 28.03 mL/min/1.73 m(2) vs. 101.15 +/- 27.32 mL/min/1.73 m(2); p = 0.032). Cimetidine administration reduced Ccr by 10% in both groups. The ratio of Ccr to mGFR was significantly above one in seven BEN patients and five controls and their mGFR values were similar. Seven other patients and eight controls had this ratio equal to one, while values below one were recorded for seven more patients and two controls. mGFR of all these 14 patients was significantly higher than that of healthy controls (129.88 +/- 27.52 mL/min/1.73 m(2) vs. 107.43 +/- 19.51 mL/min/1.73 m(2); p = 0.009). Mean GFR-HF was significantly higher than mGFR in controls, but these two values were similar in BEN patients. eGFR underestimated mGFR in both BEN patients and controls. Conclusion: The ratio of Ccr to mGFR and mGFR to GFR-HF indicated that elevated mGFR in early stages of BEN could be explained by increased glomerular filtration, but tubular creatinine secretion augmented Ccr in a smaller proportion of patients, who did not differ from healthy subjects.
PB  - MDPI, Basel
T2  - Medicina-Lithuania
T1  - Increased Glomerular Filtration Rate in Early Stage of Balkan Endemic Nephropathy
VL  - 55
IS  - 5
DO  - 10.3390/medicina55050155
ER  - 
@article{
author = "Đukanović, Ljubica and Lezaić, Višnja and Bukvić, Danica and Mirković, Duško and Marić, Ivko",
year = "2019",
abstract = "Background: A previous study indicated that Balkan endemic nephropathy (BEN) patients in the early stage of the disease had significantly higher creatinine clearance (Ccr) than healthy persons. The aim of the study was to assess whether tubular creatinine secretion affects Ccr in early stages of BEN and to check the applicability of serum creatinine-based glomerular filtration rate (GFR) equations in these patients. Methods: The study involved 21 BEN patients with estimated GFR (eGFR) above 60 mL/min/1.73 m(2), excluding any conditions that could affect GFR or tubular creatinine secretion, and 15 healthy controls. In all participants Ccr with and without cimetidine and iohexol clearance (mGFR) were measured and eGFR calculated using Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease Study (MDRD) equations. Glomerular hyperfiltration cutoff (GFR-HF) was calculated. Results: There was no significant difference between the groups in Ccr before and after cimetidine or for eGFR, but mGFR was significantly higher in BEN patients than in controls (122.02 +/- 28.03 mL/min/1.73 m(2) vs. 101.15 +/- 27.32 mL/min/1.73 m(2); p = 0.032). Cimetidine administration reduced Ccr by 10% in both groups. The ratio of Ccr to mGFR was significantly above one in seven BEN patients and five controls and their mGFR values were similar. Seven other patients and eight controls had this ratio equal to one, while values below one were recorded for seven more patients and two controls. mGFR of all these 14 patients was significantly higher than that of healthy controls (129.88 +/- 27.52 mL/min/1.73 m(2) vs. 107.43 +/- 19.51 mL/min/1.73 m(2); p = 0.009). Mean GFR-HF was significantly higher than mGFR in controls, but these two values were similar in BEN patients. eGFR underestimated mGFR in both BEN patients and controls. Conclusion: The ratio of Ccr to mGFR and mGFR to GFR-HF indicated that elevated mGFR in early stages of BEN could be explained by increased glomerular filtration, but tubular creatinine secretion augmented Ccr in a smaller proportion of patients, who did not differ from healthy subjects.",
publisher = "MDPI, Basel",
journal = "Medicina-Lithuania",
title = "Increased Glomerular Filtration Rate in Early Stage of Balkan Endemic Nephropathy",
volume = "55",
number = "5",
doi = "10.3390/medicina55050155"
}
Đukanović, L., Lezaić, V., Bukvić, D., Mirković, D.,& Marić, I.. (2019). Increased Glomerular Filtration Rate in Early Stage of Balkan Endemic Nephropathy. in Medicina-Lithuania
MDPI, Basel., 55(5).
https://doi.org/10.3390/medicina55050155
Đukanović L, Lezaić V, Bukvić D, Mirković D, Marić I. Increased Glomerular Filtration Rate in Early Stage of Balkan Endemic Nephropathy. in Medicina-Lithuania. 2019;55(5).
doi:10.3390/medicina55050155 .
Đukanović, Ljubica, Lezaić, Višnja, Bukvić, Danica, Mirković, Duško, Marić, Ivko, "Increased Glomerular Filtration Rate in Early Stage of Balkan Endemic Nephropathy" in Medicina-Lithuania, 55, no. 5 (2019),
https://doi.org/10.3390/medicina55050155 . .
1
1
1

The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients

Lezaić, Višnja; Petković, Nenad; Marić, Ivko; Miljković, Branislava; Vučićević, Katarina; Simić-Ogrizović, Sanja; Pejović, Vesna; Đukanović, Ljubica

(Soc Espanola Nefrologia Dr Rafael Matesanz, Madrid, 2013)

TY  - JOUR
AU  - Lezaić, Višnja
AU  - Petković, Nenad
AU  - Marić, Ivko
AU  - Miljković, Branislava
AU  - Vučićević, Katarina
AU  - Simić-Ogrizović, Sanja
AU  - Pejović, Vesna
AU  - Đukanović, Ljubica
PY  - 2013
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1882
AB  - Background: Balkan endemic nephropathy (BEN) hemodialysis patients require a higher dose of recombinant human erythropoietin for maintaining target hemoglobin level than patients with other kidney diseases. Objectives: Comparison of the pharmacokinetics of beta-erythropoietin given subcutaneously to hemodialysis patients with BEN or other kidney diseases (non-BEN). Methods: Recombinant human erythropoietin (75U/kg) was administered subcutaneously to 10 BEN and 14 non-BEN hemodialysis patients. The predose plasma level of erythropoietin (Epo) was subtracted from all postdose levels. The relevant pharmacokinetic parameters were calculated after noncompartmental pharmacokinetic analysis using Kinetica software (Thermo Scientific, ver.5.0). Results: Although basal plasma Epo concentration was similar in BEN (20.1 +/- 10.3U/L) and non-BEN (15.1 +/- 8.1U/L; p=.1964) patients, there were significant differences between the groups for elimination rate constant (0.016 +/- 0.006 vs 0.026 +/- 0.011 hr(-1); p=.020) and elimination half-life (50.24 +/- 19.12 vs 33.79 +/- 18.91 hr, p=.048). These differences remained significant after adjustment for patient characteristics (age, sex, hennodialysis duration, ferritin, PTH and ACEI use). No significant differences between groups were found in maximal Epo concentration, time to maximum Epo concentration, area under the curve from time of dosing extrapolated to infinity, clearance, mean residence time of Epo between groups both before and after adjustment. Conclusion: Pharmacokinetic analysis of beta-erythropoietin detected a significantly longer elimination half-life in BEN than in non BEN patients. This finding needs to be confirmed in a well-controlled study with a larger sample size.
PB  - Soc Espanola Nefrologia Dr Rafael Matesanz, Madrid
T2  - Nefrologia
T1  - The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients
VL  - 33
IS  - 4
SP  - 478
EP  - 485
DO  - 10.3265/Nefrologia.pre2013.Apr.11800
ER  - 
@article{
author = "Lezaić, Višnja and Petković, Nenad and Marić, Ivko and Miljković, Branislava and Vučićević, Katarina and Simić-Ogrizović, Sanja and Pejović, Vesna and Đukanović, Ljubica",
year = "2013",
abstract = "Background: Balkan endemic nephropathy (BEN) hemodialysis patients require a higher dose of recombinant human erythropoietin for maintaining target hemoglobin level than patients with other kidney diseases. Objectives: Comparison of the pharmacokinetics of beta-erythropoietin given subcutaneously to hemodialysis patients with BEN or other kidney diseases (non-BEN). Methods: Recombinant human erythropoietin (75U/kg) was administered subcutaneously to 10 BEN and 14 non-BEN hemodialysis patients. The predose plasma level of erythropoietin (Epo) was subtracted from all postdose levels. The relevant pharmacokinetic parameters were calculated after noncompartmental pharmacokinetic analysis using Kinetica software (Thermo Scientific, ver.5.0). Results: Although basal plasma Epo concentration was similar in BEN (20.1 +/- 10.3U/L) and non-BEN (15.1 +/- 8.1U/L; p=.1964) patients, there were significant differences between the groups for elimination rate constant (0.016 +/- 0.006 vs 0.026 +/- 0.011 hr(-1); p=.020) and elimination half-life (50.24 +/- 19.12 vs 33.79 +/- 18.91 hr, p=.048). These differences remained significant after adjustment for patient characteristics (age, sex, hennodialysis duration, ferritin, PTH and ACEI use). No significant differences between groups were found in maximal Epo concentration, time to maximum Epo concentration, area under the curve from time of dosing extrapolated to infinity, clearance, mean residence time of Epo between groups both before and after adjustment. Conclusion: Pharmacokinetic analysis of beta-erythropoietin detected a significantly longer elimination half-life in BEN than in non BEN patients. This finding needs to be confirmed in a well-controlled study with a larger sample size.",
publisher = "Soc Espanola Nefrologia Dr Rafael Matesanz, Madrid",
journal = "Nefrologia",
title = "The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients",
volume = "33",
number = "4",
pages = "478-485",
doi = "10.3265/Nefrologia.pre2013.Apr.11800"
}
Lezaić, V., Petković, N., Marić, I., Miljković, B., Vučićević, K., Simić-Ogrizović, S., Pejović, V.,& Đukanović, L.. (2013). The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients. in Nefrologia
Soc Espanola Nefrologia Dr Rafael Matesanz, Madrid., 33(4), 478-485.
https://doi.org/10.3265/Nefrologia.pre2013.Apr.11800
Lezaić V, Petković N, Marić I, Miljković B, Vučićević K, Simić-Ogrizović S, Pejović V, Đukanović L. The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients. in Nefrologia. 2013;33(4):478-485.
doi:10.3265/Nefrologia.pre2013.Apr.11800 .
Lezaić, Višnja, Petković, Nenad, Marić, Ivko, Miljković, Branislava, Vučićević, Katarina, Simić-Ogrizović, Sanja, Pejović, Vesna, Đukanović, Ljubica, "The Pharmacokinetics of Recombinant Human Erythropoietin in Balkan Endemic Nephropathy Patients" in Nefrologia, 33, no. 4 (2013):478-485,
https://doi.org/10.3265/Nefrologia.pre2013.Apr.11800 . .

Potential Influence of Tubular Dysfunction on the Difference Between Estimated and Measured Glomerular Filtration Rate After Kidney Transplantation

Lezaić, V.; Mirković, Duško; Ristić, S.; Radivojević, Dragana; Dajak, Marijana; Naumović, Radomir; Marinković, Jelena; Đukanović, Ljubica

(Elsevier Science Inc, New York, 2013)

TY  - JOUR
AU  - Lezaić, V.
AU  - Mirković, Duško
AU  - Ristić, S.
AU  - Radivojević, Dragana
AU  - Dajak, Marijana
AU  - Naumović, Radomir
AU  - Marinković, Jelena
AU  - Đukanović, Ljubica
PY  - 2013
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1963
AB  - Purpose. Because no consensus exists regarding the most accurate calculation to estimate glomerular filtration rate (GFR) based on serum creatinine concentrations (sCr) after kidney transplantation, this study sought to assess the potential role of tubular dysfunction on GFR estimates using various equations as well as the effect of pharmacologic blockades on tubular secretion of creatinine on creatinine clearance (ClCr). Methods. Iohexol GFR (mGFR) was performed in 17 stable kidney transplant recipients(R) at >24 months post-transplantation. Their mean age was 48.3 +/- 11.3 years. All R were treated with a calcineurin inhibitor (CNI). At the time of study we measured sCr, 24 hour-ClCr, cystatin C, 24-hour proteinuria, microalbuminuria, FE Na, alfa1-microglobulinuria (alfa1-MG), and CNI concentrations. To block tubular secretion of Cr, recipients were prescribed cimetidine (2400 mg) 2 days before the sCr measurement. Additionally, to exclude dietary influences on sCr, R did not eat meat for 2 days before testing. GFR was estimated using the Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), Cockroft-Gault (C&G), and Cystatin C (Cyst C) GFR equations. Mean kidney graft function over the previous 6 months was used as the contra. Pearson correlation was determined between the differences between mGFR and estimatedGFR: Iohexol minus MDRD, EPI, Cyst C or C&G GFR for paired estimates. The diagnostic accuracy of the eGFRs to detect an mGFR of 60 mL/min/1.73 m(2) was examined by receiver operating characteristic curves. Results. Mean mGFR was 75.2 +/- 35.8 mL/min/1.73 m2. The sCr increased but the 24-hour ClCr, MDRD, EPI, and C&G decreased after vs before cimetidine. The difference was significant for sCr (F = 12.933; P = .002) and MDRD GFR (F = 15.750; P = .001). mGFR was not significantly higher than all pair values of eGFRs, and not significantly lower than 24-hour ClCr before and after cimetidine. However, in comparison to all eGFRs, ClCr after cimetidine most approached mGFR. A significant positive correlation was observed between alfa1-MG and the difference between mGFR and MDRD (before, r = .543 [P = .045]; after cimeticline, 0.568 [P = .034]), EPI (before, r = 0.516 [P = .050]; after cimetidine, r = 0.562 [P = .0361), and ClCr (r = 0.633; P = .016), C&G (P = .581; P = .029) before cimetidine. Accuracy of eGFRs to detect mGFR of 60 mL/min/1.73 m(2) showed EPI GFR before cimetidine to show diagnostic accuracy for patients with GFR >60 mL/min/1.73 m(2) with a sensitivity of 81.8% and a specificity of 71.4%.
PB  - Elsevier Science Inc, New York
T2  - Turkish Journal of Medical Sciences
T1  - Potential Influence of Tubular Dysfunction on the Difference Between Estimated and Measured Glomerular Filtration Rate After Kidney Transplantation
VL  - 45
IS  - 4
SP  - 1651
EP  - 1654
DO  - 10.1016/j.transproceed.2013.02.105
ER  - 
@article{
author = "Lezaić, V. and Mirković, Duško and Ristić, S. and Radivojević, Dragana and Dajak, Marijana and Naumović, Radomir and Marinković, Jelena and Đukanović, Ljubica",
year = "2013",
abstract = "Purpose. Because no consensus exists regarding the most accurate calculation to estimate glomerular filtration rate (GFR) based on serum creatinine concentrations (sCr) after kidney transplantation, this study sought to assess the potential role of tubular dysfunction on GFR estimates using various equations as well as the effect of pharmacologic blockades on tubular secretion of creatinine on creatinine clearance (ClCr). Methods. Iohexol GFR (mGFR) was performed in 17 stable kidney transplant recipients(R) at >24 months post-transplantation. Their mean age was 48.3 +/- 11.3 years. All R were treated with a calcineurin inhibitor (CNI). At the time of study we measured sCr, 24 hour-ClCr, cystatin C, 24-hour proteinuria, microalbuminuria, FE Na, alfa1-microglobulinuria (alfa1-MG), and CNI concentrations. To block tubular secretion of Cr, recipients were prescribed cimetidine (2400 mg) 2 days before the sCr measurement. Additionally, to exclude dietary influences on sCr, R did not eat meat for 2 days before testing. GFR was estimated using the Modification of Diet in Renal Disease (MDRD), Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI), Cockroft-Gault (C&G), and Cystatin C (Cyst C) GFR equations. Mean kidney graft function over the previous 6 months was used as the contra. Pearson correlation was determined between the differences between mGFR and estimatedGFR: Iohexol minus MDRD, EPI, Cyst C or C&G GFR for paired estimates. The diagnostic accuracy of the eGFRs to detect an mGFR of 60 mL/min/1.73 m(2) was examined by receiver operating characteristic curves. Results. Mean mGFR was 75.2 +/- 35.8 mL/min/1.73 m2. The sCr increased but the 24-hour ClCr, MDRD, EPI, and C&G decreased after vs before cimetidine. The difference was significant for sCr (F = 12.933; P = .002) and MDRD GFR (F = 15.750; P = .001). mGFR was not significantly higher than all pair values of eGFRs, and not significantly lower than 24-hour ClCr before and after cimetidine. However, in comparison to all eGFRs, ClCr after cimetidine most approached mGFR. A significant positive correlation was observed between alfa1-MG and the difference between mGFR and MDRD (before, r = .543 [P = .045]; after cimeticline, 0.568 [P = .034]), EPI (before, r = 0.516 [P = .050]; after cimetidine, r = 0.562 [P = .0361), and ClCr (r = 0.633; P = .016), C&G (P = .581; P = .029) before cimetidine. Accuracy of eGFRs to detect mGFR of 60 mL/min/1.73 m(2) showed EPI GFR before cimetidine to show diagnostic accuracy for patients with GFR >60 mL/min/1.73 m(2) with a sensitivity of 81.8% and a specificity of 71.4%.",
publisher = "Elsevier Science Inc, New York",
journal = "Turkish Journal of Medical Sciences",
title = "Potential Influence of Tubular Dysfunction on the Difference Between Estimated and Measured Glomerular Filtration Rate After Kidney Transplantation",
volume = "45",
number = "4",
pages = "1651-1654",
doi = "10.1016/j.transproceed.2013.02.105"
}
Lezaić, V., Mirković, D., Ristić, S., Radivojević, D., Dajak, M., Naumović, R., Marinković, J.,& Đukanović, L.. (2013). Potential Influence of Tubular Dysfunction on the Difference Between Estimated and Measured Glomerular Filtration Rate After Kidney Transplantation. in Turkish Journal of Medical Sciences
Elsevier Science Inc, New York., 45(4), 1651-1654.
https://doi.org/10.1016/j.transproceed.2013.02.105
Lezaić V, Mirković D, Ristić S, Radivojević D, Dajak M, Naumović R, Marinković J, Đukanović L. Potential Influence of Tubular Dysfunction on the Difference Between Estimated and Measured Glomerular Filtration Rate After Kidney Transplantation. in Turkish Journal of Medical Sciences. 2013;45(4):1651-1654.
doi:10.1016/j.transproceed.2013.02.105 .
Lezaić, V., Mirković, Duško, Ristić, S., Radivojević, Dragana, Dajak, Marijana, Naumović, Radomir, Marinković, Jelena, Đukanović, Ljubica, "Potential Influence of Tubular Dysfunction on the Difference Between Estimated and Measured Glomerular Filtration Rate After Kidney Transplantation" in Turkish Journal of Medical Sciences, 45, no. 4 (2013):1651-1654,
https://doi.org/10.1016/j.transproceed.2013.02.105 . .
3
3
3

Pharmacokinetics of erythropoietin in Balkan endemic nephropathy patients

Lezaić, Višnja; Miljković, Branislava; Petković, Nenad; Marić, Ivko; Vučićević, Katarina; Simić-Ogrizović, Sanja; Đukanović, Ljubica

(Oxford Univ Press, Oxford, 2012)

TY  - CONF
AU  - Lezaić, Višnja
AU  - Miljković, Branislava
AU  - Petković, Nenad
AU  - Marić, Ivko
AU  - Vučićević, Katarina
AU  - Simić-Ogrizović, Sanja
AU  - Đukanović, Ljubica
PY  - 2012
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1677
PB  - Oxford Univ Press, Oxford
C3  - Nephrology Dialysis Transplantation
T1  - Pharmacokinetics of erythropoietin in Balkan endemic nephropathy patients
VL  - 27
SP  - 142
EP  - 142
UR  - https://hdl.handle.net/21.15107/rcub_farfar_1677
ER  - 
@conference{
author = "Lezaić, Višnja and Miljković, Branislava and Petković, Nenad and Marić, Ivko and Vučićević, Katarina and Simić-Ogrizović, Sanja and Đukanović, Ljubica",
year = "2012",
publisher = "Oxford Univ Press, Oxford",
journal = "Nephrology Dialysis Transplantation",
title = "Pharmacokinetics of erythropoietin in Balkan endemic nephropathy patients",
volume = "27",
pages = "142-142",
url = "https://hdl.handle.net/21.15107/rcub_farfar_1677"
}
Lezaić, V., Miljković, B., Petković, N., Marić, I., Vučićević, K., Simić-Ogrizović, S.,& Đukanović, L.. (2012). Pharmacokinetics of erythropoietin in Balkan endemic nephropathy patients. in Nephrology Dialysis Transplantation
Oxford Univ Press, Oxford., 27, 142-142.
https://hdl.handle.net/21.15107/rcub_farfar_1677
Lezaić V, Miljković B, Petković N, Marić I, Vučićević K, Simić-Ogrizović S, Đukanović L. Pharmacokinetics of erythropoietin in Balkan endemic nephropathy patients. in Nephrology Dialysis Transplantation. 2012;27:142-142.
https://hdl.handle.net/21.15107/rcub_farfar_1677 .
Lezaić, Višnja, Miljković, Branislava, Petković, Nenad, Marić, Ivko, Vučićević, Katarina, Simić-Ogrizović, Sanja, Đukanović, Ljubica, "Pharmacokinetics of erythropoietin in Balkan endemic nephropathy patients" in Nephrology Dialysis Transplantation, 27 (2012):142-142,
https://hdl.handle.net/21.15107/rcub_farfar_1677 .

Potential Influence of Tubular Dysfunction in Agreement of Estimated and Measured Glomerular Fultration Rate after Kidney Transplantation

Lezaić, V; Mirković, Duško; Ristić, S.; Radivojević, Dragana; Dajak, Marijana; Naumović, Radomir; Đukanović, Ljubica

(Lippincott Williams & Wilkins, Philadelphia, 2012)

TY  - CONF
AU  - Lezaić, V
AU  - Mirković, Duško
AU  - Ristić, S.
AU  - Radivojević, Dragana
AU  - Dajak, Marijana
AU  - Naumović, Radomir
AU  - Đukanović, Ljubica
PY  - 2012
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/1658
PB  - Lippincott Williams & Wilkins, Philadelphia
C3  - Transplantation Proceedings
T1  - Potential Influence of Tubular Dysfunction in Agreement of Estimated and Measured Glomerular Fultration Rate after Kidney Transplantation
VL  - 94
IS  - 10
SP  - 873
EP  - 873
DO  - 10.1097/00007890-201211271-01718
ER  - 
@conference{
author = "Lezaić, V and Mirković, Duško and Ristić, S. and Radivojević, Dragana and Dajak, Marijana and Naumović, Radomir and Đukanović, Ljubica",
year = "2012",
publisher = "Lippincott Williams & Wilkins, Philadelphia",
journal = "Transplantation Proceedings",
title = "Potential Influence of Tubular Dysfunction in Agreement of Estimated and Measured Glomerular Fultration Rate after Kidney Transplantation",
volume = "94",
number = "10",
pages = "873-873",
doi = "10.1097/00007890-201211271-01718"
}
Lezaić, V., Mirković, D., Ristić, S., Radivojević, D., Dajak, M., Naumović, R.,& Đukanović, L.. (2012). Potential Influence of Tubular Dysfunction in Agreement of Estimated and Measured Glomerular Fultration Rate after Kidney Transplantation. in Transplantation Proceedings
Lippincott Williams & Wilkins, Philadelphia., 94(10), 873-873.
https://doi.org/10.1097/00007890-201211271-01718
Lezaić V, Mirković D, Ristić S, Radivojević D, Dajak M, Naumović R, Đukanović L. Potential Influence of Tubular Dysfunction in Agreement of Estimated and Measured Glomerular Fultration Rate after Kidney Transplantation. in Transplantation Proceedings. 2012;94(10):873-873.
doi:10.1097/00007890-201211271-01718 .
Lezaić, V, Mirković, Duško, Ristić, S., Radivojević, Dragana, Dajak, Marijana, Naumović, Radomir, Đukanović, Ljubica, "Potential Influence of Tubular Dysfunction in Agreement of Estimated and Measured Glomerular Fultration Rate after Kidney Transplantation" in Transplantation Proceedings, 94, no. 10 (2012):873-873,
https://doi.org/10.1097/00007890-201211271-01718 . .